Atrys Health retains Norgestión and Deloitte to debut in the continuous stock market
Atrys Health habría encargado a Norgestión y Deloitte su salto en el Mercado Continuo
Intel ID : 323859
|
||||
| Intel ID | 323859 | ||
| Value | ND | ||
| Native Currency | Euro (EUR) | ||
|
Financial Data - Atrys Health
(31 Dec 2021) |
Revenue: EUR 127,84m EBITDA: EUR 5,78m Net Debt: EUR 816,41m |
||
| Date |
 |
||
| Country |  |
||
| Geography | |
||
| Subsector (Old TTR Sectors) |
|
||
| Type |
|
||
| Intel Grade |
|
||
| Source |
|
||
| Tags | |
Issuer
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
30.03.03 Diagnostic, Imaging & Laboratory Services 30 Healthcare / 30.03 Healthcare Facilities & Services |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Financial Advisory
| Parties | Advisor | Notes from Advisors | |||||
|---|---|---|---|---|---|---|---|
|
|
- | |||||
|
- |
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.